ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,727Medicare Part D Prescriptions Filled, Including Refills

Rank: 369 out of 6969

$513K Total Retail Price of All Prescriptions

Rank: 561 out of 6969

706 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 706 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,198 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 621 603 1 5
ATENOLOL 395 387 2 9
SIMVASTATIN 370 360 3 1
LISINOPRIL 369 335 4 2
LOVASTATIN 330 297 5 15
AMLODIPINE BESYLATE 320 304 6 4
OMEPRAZOLE 297 275 7 6
HYDROCHLOROTHIAZIDE 222 213 8 8
METFORMIN HCL 220 211 9 7
CITALOPRAM HBR 207 199 10 34
NAMENDA 196 196 11 51
METOPROLOL TARTRATE 190 177 12 13
FUROSEMIDE 170 159 13 10
WARFARIN SODIUM 166 152 14 20
ZOLPIDEM TARTRATE 162 146 15 16
HYDROCODONE-ACETAMINOPHEN 158 153 S3 16 3
LOSARTAN POTASSIUM 157 143 17 12
METOPROLOL SUCCINATE 147 147 18 22
ATORVASTATIN CALCIUM 144 144 19 11
SYNTHROID 140 140 20 94
POTASSIUM CHLORIDE 139 128 21 30
PANTOPRAZOLE SODIUM 130 125 22 31
GABAPENTIN 126 125 23 17
DONEPEZIL HCL 123 123 24 32
DIGOXIN 114 114 25 71
TRIAMTERENE-HCTZ 113 103 26 58
DIOVAN 110 110 27 26
ALENDRONATE SODIUM 104 100 28 14
MIRTAZAPINE 102 97 29 76
LOSARTAN-HYDROCHLOROTHIAZIDE 101 100 30 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 91 31 28
PRAVASTATIN SODIUM 98 97 32 19
BENAZEPRIL HCL 83 71 33 18
GLIMEPIRIDE 80 70 34 44
TRAMADOL HCL-ACETAMINOPHEN 79 78 35 279
ALPRAZOLAM 77 76 36 172
CARVEDILOL 75 72 37 25
ESTRADIOL 74 59 R 38 124
SERTRALINE HCL 72 72 39 38
CIPROFLOXACIN HCL 72 70 39 64
CLOPIDOGREL 70 70 41 48
ALLOPURINOL 63 54 42 35
LEVOXYL 61 61 43 122
ESCITALOPRAM OXALATE 57 57 44 93
TEMAZEPAM 56 56 45 251
ZETIA 55 55 46 98
POLYETHYLENE GLYCOL 3350 55 55 46 127
QUETIAPINE FUMARATE 53 52 48 101
PREMARIN 52 51 R 49 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.